This paradigm may lead to novel skin cancer treatments, and pave the way to treat other cancers with elevated PDPN expression levels including breast [20], [24], glioma [21], and oral cancer [25], [26]. The gene discussed is PDPN; the disease is lip and oral cavity carcinoma.